InvestorsHub Logo
Followers 0
Posts 142
Boards Moderated 0
Alias Born 11/30/2017

Re: None

Tuesday, 04/21/2020 10:13:36 AM

Tuesday, April 21, 2020 10:13:36 AM

Post# of 97081
I really enjoyed reading today's PR.

I like how it goes into the science of different types of tests: Serology and PCR based.

With so many tests out there, it’s important to know the differences!

There is lot of commentary about serology testing from talking heads, it’s nice to have some clarification.

I think it’s important to know that serology-based testing, in regards to Covid, are the antibody based tests. These are the types of tests that the FDA have been hard on.

DECN’s test that has Pre-EUA uses blood also, but it is not a serology-based test.

DECN’s product that is before the FDA right now is a blood-based test but does not test for antibodies. They are using their proprietary electrical impedance to test for Covid. This technology has been developed and refined by DECN throughout the years, first showing up in their diabetes product. I believe some sort of tweaking would have to be done to translate this technology for Covid. This is extremely cool, and I am excited to hear more. I’m sure this is no easy task, but I’m confident in Mr. Berman’s and Dr. Musho’s abilities. I read a bit about the engineering behind all this stuff, certainly not easy to understand and complicated. As an investor it’s important to have foresight and look down the road, not a few feet in front of you. Patience will be rewarded, what is before the FDA right now is a game changing product, we need it.